8:50 -10:20  a.m.    Clinical Trial Designs for Evaluating Treatment Effect in Subpopulations


 

Clinical Trial Designs for Evaluating Treatment Effect in Subpopulations

Organizer: H.M. James Hung (Food and Drug Administration, U.S.A.)
and Sue-Jane Wang (Food and Drug Administration, U.S.A.)

Email: hsienming.hung@fda.hhs.gov  &  suejane.wang@fda.hhs.gov

Chair: H.M. James Hung (Food and Drug Administration, U.S.A.)

Email: hsienming.hung@fda.hhs.gov

 

 

  8:509:20

 

Speakers:

Chin-Fu Hsiao

National Health Research Institutes, Taiwan, R.O.C.

Email: chinfu@nhri.org.tw

Title: Use of Prior Information for Bayesian Evaluation of Bridging Studies

 

  9:209:50

 

H.M. James Hung

Office of Biostatistics, OTS/CDER, Food and Drug Administration, U.S.A.

Email: hsienming.hung@fda.hhs.gov

Title: Statistical Frameworks of Clinical Trial Design for Evaluating Treatment Effect in Subpopulations

 

  9:5010:20

 

Satoshi Morita

Program in Health and Community Medicine, Nagoya University Graduate

School of Medicine, Japan

Email: smorita@med.nagoya-u.ac.jp

Title: Case Study of a Clinical Trial for A Molecular Targeting Anti-Cancer Drug

 

  Page Up